Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study).

Azim L, Hindmarch P, Browne G, Chadwick T, Clare E, Courtney P, et al. (2021) BMC Psychiatry.

'COVID-DO-IT-ALL': We need integrated protection systems and strategies against omicron and other COVID-19 variants

Lopes H, McCallum A, Reid J, Simon J, Wong B, Mason-Jones A, Middleton J (2021) ASPHER (The..

Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.

Dillinger T, Sheibani-Tezerji R, Pulverer W, Stelzer I, Hassler MR, Scheibelreiter J, et al. (2022)..

Establishing a comprehensive list of mental health-related services and resource use items in Austria: A national-level, cross-sectoral country report for the PECUNIA project

Fischer C, Mayer S, Perić N, Simon J on behalf of the PECUNIA Group. (2022) PLoS One

In search for comparability: The PECUNIA reference unit costs for health and social care services in Europe.

Mayer S, Berger M, Konnopka A, Brodszky V, Evers SMAA, Hakkaart-van Roijen L, et al. on behalf of..

PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.

Au-Yeung SK, Griffiths J, Roberts S, Edwards C, Yu LM, Bogacz R, et al (2022) BMJ Evid Based Ment..

Patient-reported outcome measures suitable for quality of life/wellbeing assessment in multi-sectoral, multi-national and multi-person mental health (economic) evaluations.

Laszewska A, Helter TM, Nagel A, Peric N, Simon J. (2022) Evid Based Ment Health.